PharmaCyte Biotech (PMCB) Other financing activities (2011 - 2023)
PharmaCyte Biotech (PMCB) posted quarterly Other financing activities of $70.0 for Q3 2023, down 92.05% year-over-year from $880.0 in Q3 2022, and down 92.05% quarter-over-quarter from $880.0 in Q3 2022.
PharmaCyte Biotech (PMCB) Other financing activities (2011 - 2023) Analysis & Trends
PharmaCyte Biotech (PMCB) has reported Other financing activities for 4 consecutive years, with $70.0 the latest figure, recorded in Q3 2023.
- In Q3 2023, Other financing activities fell 92.05% year-over-year to $70.0; the TTM figure through Apr 2024 stood at $70.0 (down 92.05% YoY), while the FY2026 annual figure was $1.0 million, changed N/A from the prior year.
- Other financing activities eased to $70.0 in Q3 2023 per PMCB's latest filing, from $880.0 in the prior quarter.
- Across five years, Other financing activities topped out at $20.9 million in Q4 2021 and bottomed at -$31.7 million in Q2 2022.
- Historically, Other financing activities has averaged -$2.7 million across 3 years, with a median of $475.0 in 2022.
- On a YoY basis, Other financing activities climbed as much as 92.05% in 2023 and fell as far as 92.05% in 2023.
- PharmaCyte Biotech's Other financing activities stood at $20.9 million in 2021, then tumbled by 100.0% to $880.0 in 2022, then sank by 92.05% to $70.0 in 2023.
- Business Quant data shows PMCB's Other financing activities at $70.0 in Q3 2023, $880.0 in Q3 2022, and -$31.7 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.08 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.11 Bn | 78.11 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn |
| 4 | Moderna | 56.09 Bn | 50.96 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.49 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - |
| 10 | PharmaCyte Biotech | 4.48 Mn | 4.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2023 | 70.00 |
| Jul 31, 2023 | 70.00 |
| Jul 31, 2022 | 880.00 |
| Jul 31, 2022 | 880.00 |
| Apr 30, 2022 | -31.67 Mn |
| Apr 30, 2022 | -31.67 Mn |
| Oct 31, 2021 | 20.95 Mn |
| Oct 31, 2021 | 20.95 Mn |
| Apr 30, 2011 | 28,229.00 |
| Apr 30, 2011 | 28,229.00 |